drugset

drugset / Trial / NCT03708627

Bimatoprost as a Treatment for Graves' Orbitopathy

NCT03708627 ↗

Phase 0 Recruiting 3 enrolled Johns Hopkins University

Non-randomizedParallel-groupSingle-blindTreatment

Summary

Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease

Timeline

Start: 2017-11-01
Primary completion: 2029-07-01
Completion: 2031-07-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bimatoprost	Other / unclassified	—	Topical

Indications